Liminatus Pharma LIMN
NASDAQ LIMN
$3.22 +0.11 (+3.54%)
As of: Oct 20, 2026 · 2:26 PM EDT

Liminatus Pharma (LIMN) Receivables - Other (2024 - 2025)

Updated

Liminatus Pharma (LIMN) recorded Receivables - Other of $126,275 in Q3 2025, unchanged from the prior quarter.

Analysis

Liminatus Pharma (LIMN) Receivables - Other (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Liminatus Pharma 3.12 Mn -2.87 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 126,275.00
Jun 30, 2025 126,275.00
Dec 31, 2024 126,275.00
API Access

Liminatus Pharma Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=LIMN&period=max&api_key=YOUR_API_KEY